SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-20-000163
Filing Date
2020-01-28
Accepted
2020-01-28 16:31:36
Documents
1
Period of Report
2019-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 8379
  Complete submission text file 0001640334-20-000163.txt   10274
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9
Business Address OFFICE 8262 THE LANDING, 200-375 WATER ST. VANCOUVER A1 V6B 0M9 858-361-4499
Emerald Health Sciences Inc. (Reporting) CIK: 0001728413 (see all company filings)

State of Incorp.: A1 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-55136 | Film No.: 20554760